Insys Therapeutics, Inc.
🏢 View company profile →7Patents
7Active
7Granted
46Portfolio score
Filing activity: Dec 9, 2005 → May 15, 2013 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8222292B2 | Liquid cannabinoid formulations | Human Necessities | 53 | Active |
| US8835459B2 | Sublingual fentanyl spray | Human Necessities | 28 | Active |
| US8628796B2 | Room-temperature stable dronabinol formulations | Human Necessities | 11 | Active |
| US8486973B2 | Sublingual fentanyl spray | Human Necessities | 6 | Active |
| US8486972B2 | Sublingual fentanyl spray | Human Necessities | 5 | Active |
| US8835460B2 | Sublingual fentanyl spray and methods of treating pain | Human Necessities | 2 | Active |
| US8741341B2 | Manufacturing and packaging room temperature stable dronabinol capsules | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.